Filter Results:
(484)
Show Results For
- All HBS Web
(906)
- People (2)
- News (238)
- Research (484)
- Events (4)
- Multimedia (3)
- Faculty Publications (229)
Show Results For
- All HBS Web
(906)
- People (2)
- News (238)
- Research (484)
- Events (4)
- Multimedia (3)
- Faculty Publications (229)
Sort by
- 01 Sep 2009
- First Look
First Look: September 1
649-651 Abstract In my second week of medical internship, I received a "friend request" on Facebook, the popular social-networking Web site. The name of the requester was familiar: Erica Baxter. Three years earlier, as a View Details
Keywords: Martha Lagace
- February 2024
- Article
Representation and Extrapolation: Evidence from Clinical Trials
By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
This article examines the consequences and causes of low enrollment of Black patients in clinical
trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is
more relevant for decision-making by physicians and patients when it... View Details
Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry
Alsan, Marcella, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein, and Heidi L. Williams. "Representation and Extrapolation: Evidence from Clinical Trials." Quarterly Journal of Economics 139, no. 1 (February 2024): 575–635.
- 21 Feb 2012
- First Look
First Look: Feb. 21
information is a central determinant of a firm's demand function, even for purchases as large as college attendance. When Do User Innovators Start Firms? A Theory of User Entrepreneurship Authors:Sonali Shah and Mary Tripsas... View Details
Keywords: Sean Silverthorne
- April 1998 (Revised May 2000)
- Case
Guidant Corporation: Shaping Culture Through Systems
By: Robert L. Simons and Antonio Davila
Guidant is a successful IPO start-up selling pacemakers and defibrillators. The case describes how managers install systems to balance innovation and control. Three parts of a shareholder value strategy are described. Controls include incentive systems, beliefs... View Details
Keywords: Innovation Strategy; Corporate Strategy; Motivation and Incentives; Planning; Risk Management; Management Systems; Business Strategy; Value Creation; System; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry
Simons, Robert L., and Antonio Davila. "Guidant Corporation: Shaping Culture Through Systems." Harvard Business School Case 198-076, April 1998. (Revised May 2000.)
- 28 Feb 2017
- First Look
First Look at New Research, February 28
417-051 Vox Capital: Pioneering Impact Investing in Brazil Vox Capital was the first certified impact investing fund in Brazil. Founded in 2009, it provides early-stage capital for companies offering innovative and scalable solutions to... View Details
Keywords: Sean Silverthorne
- 02 Oct 2018
- First Look
New Research and Ideas, October 2, 2018
innovation after the anti-corruption campaign and the departure of government innovation officials. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=55038 When Does Product Liability... View Details
Keywords: Dina Gerdeman
- Article
A Field Experiment on Search Costs and the Formation of Scientific Collaborations
By: Kevin Boudreau, Tom Brady, Ina Ganguli, Patrick Gaule, Eva C. Guinan, Anthony Hollenberg and Karim R. Lakhani
We present the results of a field experiment conducted at Harvard Medical School to understand the extent to which search costs affect matching among scientific collaborators. We generated exogenous variation in search costs for pairs of potential collaborators by... View Details
Keywords: Search Costs; Cost; Marketplace Matching; Groups and Teams; Science; Collaborative Innovation and Invention
Boudreau, Kevin, Tom Brady, Ina Ganguli, Patrick Gaule, Eva C. Guinan, Anthony Hollenberg, and Karim R. Lakhani. "A Field Experiment on Search Costs and the Formation of Scientific Collaborations." Review of Economics and Statistics 99, no. 4 (October 2017): 565–576.
- March 2022 (Revised August 2022)
- Case
Proximie: Using XR Technology to Create Borderless Operating Rooms
By: Ariel D. Stern and Alpana Thapar
In mid-January 2022, Nadine Hachach-Haram, founder and CEO of Proximie, was thinking about the company’s growth plans. Launched in 2016, Proximie was a platform that enabled clinicians, proctors, and medical device company personnel to be virtually present in operating... View Details
Keywords: Growth and Development Strategy; Technological Innovation; Partners and Partnerships; Strategic Planning; Health Care and Treatment; Analytics and Data Science; Digital Platforms; Health Industry; Lebanon; United Kingdom; United States
Stern, Ariel D., and Alpana Thapar. "Proximie: Using XR Technology to Create Borderless Operating Rooms." Harvard Business School Case 622-082, March 2022. (Revised August 2022.)
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (B): The Power of Insight
By: Rosabeth M. Kanter and Michelle Heskett
Dr. Craig Feied considers how to take a major technical innovation beyond his own department into a large hospital system. Reviews how proprietary information systems became indispensable in the department of emergency medicine and what it took to introduce the change... View Details
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
says, "will kill us financially and medically it will ruin our economy, deny us the health care services we need, and undermine the important genomic research that can fundamentally improve the practice of medicine and control its... View Details
- 18 Oct 2006
- Research & Ideas
New at the Helm: A Talk with HBS Dean Light
world. Q: What other priorities do you have in mind? A: There is tremendous opportunity and need in the area of healthcare. We launched a five-year MD/MBA joint-degree program with Harvard Medical School a year ago, and it now has... View Details
- 05 Sep 2023
- Book
Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential
In the 1990s, after drugmaker Eli Lilly spent more than a decade and millions of dollars developing the new drug Alimta to treat lung cancer, the medication came up short in effectively treating cancer in expanded trials. While the... View Details
Keywords: by Michael Blanding
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- 24 Oct 2023
- HBS Case
From P.T. Barnum to Mary Kay: Lessons From 5 Leaders Who Changed the World
industry pioneer Mary Kay Ash learned about hard work, strict priorities, and the power of positive reinforcement firsthand. When she was seven, her father contracted tuberculosis, becoming housebound and requiring constant medical care.... View Details
Keywords: by Avery Forman
- 02 Jul 2019
- Working Paper Summaries
Risk-Mitigating Technologies: The Case of Radiation Diagnostic Devices
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- December 1998 (Revised March 1999)
- Case
Disruptive Technology a Heartbeat Away: Ecton, Inc.
By: Clayton M. Christensen and Edward G Cape
Describes an innovating start-up company with a disruptive technology to the large, expensive echocardiography machines that leading cardiologists use to create images of heart functions for diagnostic purposes. Ecton's machine is small, cheap, portable, and can't... View Details
Keywords: Business Startups; Disruption; Machinery and Machining; Entrepreneurship; Innovation and Invention; Marketing; Product; Commercialization; Technology; Medical Devices and Supplies Industry
Christensen, Clayton M., and Edward G Cape. "Disruptive Technology a Heartbeat Away: Ecton, Inc." Harvard Business School Case 699-018, December 1998. (Revised March 1999.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- 05 Dec 2006
- First Look
First Look: December 5, 2006
Science Foundation. The developed platform offers an unprecedented view of the R&D-to-patenting innovation process and a close analysis of the strengths and limitations of the Industry R&D Survey. The files are linked through a... View Details
Keywords: Sean Silverthorne
- 25 Oct 2016
- First Look
October 25, 2016
2016 University of Chicago Press Innovation Equity: Assessing and Managing the Monetary Value of New Products and Services By: Ofek, Elie, Eitan Muller, and Barak Libai Abstract—This book bridges the gap between what academics know, and... View Details
Keywords: Sean Silverthorne